Cerezyme 400 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSCF0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,457
Award facts
- Contract value 100% obligated
- $66,456.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $66,456.63 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cerezyme 400 unit vials. The award, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. The delivery order will be performed at the vendor's Park Ridge facility and represents a discrete purchase under the company's existing indefinite delivery contract vehicle with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.9 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V program is a $30.3 billion acquisition strategy designed to supply pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. As a prime vendor under this framework, DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through numerous prior delivery orders and serves as a critical supplier within the federal pharmaceutical supply chain for military medical operations.
Quick answers
Who was awarded contract SPE2DR26FSCF0?
SPE2DR26FSCF0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FSCF0 worth?
The government has obligated $66,457 on SPE2DR26FSCF0.
Is contract SPE2DR26FSCF0 an order under another contract?
Yes. SPE2DR26FSCF0 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCF0 competed?
The extent of competition for SPE2DR26FSCF0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award